Spotlight on raw materials and supply chain

As regenerative medicine and cell and gene therapies continue to advance, the importance of robust raw materials and resilient supply chains has never been greater. From supporting the safety and potency of cell-based products to helping meet regulatory expectations, the quality and consistency of starting materials facilitate in enabling reproducible, patient-ready therapies. 

In this Spotlight feature, we will explore the pivotal role that raw materials and supply chain management play in GMP grade manufacturing for cell and gene therapies and regenerative medicine, including the importance of sourcing and qualifying high-quality raw materials, the benefits of xeno-free and animal component-free media in reducing variability and contamination risks, and how proactive risk management approaches can strengthen supply chain resilience. 

This feature was produced in association with PromoCell (Heidelberg, Germany).